Assay for Citrate and Phosphate in Pharmaceutical Formulations Using a Compact IC System

Applications | 2016 | Thermo Fisher ScientificInstrumentation
Ion chromatography
Industries
Pharma & Biopharma
Manufacturer
Thermo Fisher Scientific

Significance of the Topic


Citrate and phosphate play critical roles in pharmaceutical formulations as buffering agents and anticoagulants. Accurate measurement ensures product quality and patient safety.

Objectives and Study Overview


This study demonstrates the determination of citrate and phosphate in pharmaceutical samples using an ion chromatography method adapted from a published protocol. The method is implemented on a compact IC system to achieve reliable results in quality control settings.

Methodology and Instrumentation


  • IC System Dionex Integrion compact system
  • Columns IonPac AS11 analytical column 4 x 250 mm with AG11 guard 4 x 50 mm
  • Eluent 20 mM potassium hydroxide generated by EGC 500 cartridge and CR-ATC trap
  • Flow rate 2 mL per min
  • Injection volume 10 microliters
  • Column temperature 30 C
  • Detection suppressed conductivity using AERS 500 suppressor at 15 C, 99 mA in recycle mode

Main Results and Discussion


The method achieved baseline separation of phosphate and citrate with retention times around 2 minutes and 4 minutes respectively. In a mixed standard solution the responses corresponded to concentrations of 12 mg per L for phosphate and 20 mg per L for citrate. In a diluted anticoagulant dextrose phosphate sample the concentrations measured were 1.4 mg per L for phosphate and 21 mg per L for citrate. Results showed reproducible performance and low detection limits.

Benefits and Practical Applications


The automated eluent generation and suppressed detection enable streamlined workflows in pharmaceutical laboratories. The method offers high throughput, consistent performance, and reduced manual preparation, making it suitable for routine quality control of formulation components.

Future Trends and Applications


Advancements may include coupling IC with mass spectrometry for enhanced specificity, miniaturization for field analysis, and integration with digital data management systems. Green chemistry approaches in eluent generation and column materials will further improve sustainability.

Conclusion


A compact IC system with automated eluent generation provides an efficient and reliable approach for simultaneous determination of citrate and phosphate in pharmaceutical formulations, meeting the demands of modern quality control laboratories.

References


1 Thermo Scientific Dionex Application Note 164 Assay for Citrate and Phosphate in Pharmaceutical Formulations Using Ion Chromatography Sunnyvale CA 2016

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Assay for Citrate and Phosphate in Pharmaceutical Formulations Using a High-Pressure Compact Ion Chromatography System
Assay for citrate and phosphate in pharmaceutical formulations using a compact IC system
Assay for Citrate and Phosphate in Pharmaceutical Formulations Using Ion Chromatography
Fast Anion Determinations in Environmental Waters Using a High-Pressure Compact Ion Chromatography System